IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 95 filers reported holding IGM BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $568,122 | -21.4% | 41,348 | -2.7% | 0.00% | -100.0% |
| Q4 2022 | $723,197 | -21.7% | 42,516 | +4.6% | 0.00% | 0.0% |
| Q3 2022 | $924,000 | +32.4% | 40,633 | +4.9% | 0.00% | 0.0% |
| Q2 2022 | $698,000 | -34.8% | 38,733 | -3.3% | 0.00% | 0.0% |
| Q1 2022 | $1,071,000 | +73.9% | 40,067 | +90.8% | 0.00% | – |
| Q4 2021 | $616,000 | -54.2% | 21,000 | +2.6% | 0.00% | -100.0% |
| Q3 2021 | $1,346,000 | -20.8% | 20,467 | +0.2% | 0.00% | -50.0% |
| Q2 2021 | $1,700,000 | +8.8% | 20,428 | +0.2% | 0.00% | 0.0% |
| Q1 2021 | $1,563,000 | -14.5% | 20,378 | -1.6% | 0.00% | 0.0% |
| Q4 2020 | $1,829,000 | -20.2% | 20,713 | -33.3% | 0.00% | -33.3% |
| Q3 2020 | $2,292,000 | +0.3% | 31,052 | -0.8% | 0.00% | 0.0% |
| Q2 2020 | $2,285,000 | +30.0% | 31,302 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $1,758,000 | +41.3% | 31,302 | -4.0% | 0.00% | +50.0% |
| Q4 2019 | $1,244,000 | – | 32,606 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,971,542 | $24,812,376 | 1.18% |
| GREAT POINT PARTNERS LLC | 615,317 | $5,137,897 | 0.94% |
| Artal Group S.A. | 2,522,244 | $21,061 | 0.90% |
| Opaleye Management Inc. | 261,000 | $2,179,350 | 0.71% |
| Samsara BioCapital, LLC | 154,664 | $1,291,444 | 0.40% |
| Bruce & Co., Inc. | 120,000 | $1,002,000 | 0.34% |
| Rhenman & Partners Asset Management AB | 200,000 | $1,670,000 | 0.18% |
| Eagle Bay Advisors LLC | 44,635 | $372,702 | 0.17% |
| RA Capital Management | 937,500 | $7,828,125 | 0.15% |
| Baker Brothers Advisors | 3,157,764 | $26,367,329 | 0.15% |